SCHEMBL4586333

SCHEMBL4586333

O=c1oc2ccccc2cc1-c1nc2ccccc2s1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.74
▸ PIK3CB P42338 1/20 0.74
▸ KDM4E B2RXH2 7/20 0.59
▸ ALDH1A1 P00352 7/20 0.59
▸ RAB9A P51151 7/20 0.59
▸ NPC1 O15118 6/20 0.59
▸ HPGD P15428 5/20 0.59
▸ SMN1; SMN2 Q16637 5/20 0.59
▸ TP53 P04637 5/20 0.59
▸ CASP1 P29466 3/20 0.59
▸ CASP7 P55210 3/20 0.59
▸ HSD17B10 Q99714 3/20 0.59
▸ MAPT P10636 7/20 0.57
▸ GLA P06280 6/20 0.57
▸ GAA P10253 2/20 0.57
▸ LMNA P02545 2/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ PKM P14618 1/20 0.57
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL4825178 0.90 PIK3CD (0.63) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL30674288 0.89 PIK3CD (0.71) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL29427470 0.85 PIK3CD (1.00) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL15065694 0.85 PIK3CD (0.74) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL29524563 0.85 PIK3CD (1.00) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL592311 0.85 PIK3CD (1.00) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL2623784 0.85 PIK3CD (0.74) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL14753532 0.85 PIK3CD (0.74) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL15398168 0.85 ALK (0.59) PIK3CDPIK3CBKDM4EALDH1A1RAB9A
SCHEMBL30165795 0.85 PIK3CD (0.74) PIK3CDPIK3CBKDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4663642-A1 POLYCYCLIC AROMATIC COMPOUND Kyoto University (JP) 2025-12-17 — — EP disclosed
US-12473315-B2 Polycyclic aromatic compound KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2025-11-18 — — US disclosed
US-20250081847-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2025-03-06 — — US disclosed
US-12185625-B2 Organic electroluminescence element, display device, and lighting device KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2024-12-31 — — US disclosed
US-20240360158-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2024-10-31 — — US disclosed
WO-2024166913-A1 POLYCYCLIC AROMATIC COMPOUND 国立大学法人京都大学 2024-08-15 — — WO disclosed
WO-2024080842-A1 ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 에스케이 주식회사 2024-04-18 — — WO disclosed
CN-117843662-A Polycyclic aromatic compound, material for organic device, organic electroluminescent element, display device, and lighting device 国立大学法人京都大学 2024-04-09 — — CN disclosed
US-11884825-B2 Exocyclic amine substituted coumarin compounds and uses as fluorescent labels ILLUMINA CAMBRIDGE LIMITED (GB) 2024-01-30 — — US disclosed
US-11877506-B2 Polycyclic aromatic compound KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2024-01-16 — — US disclosed
US-20090124688-A1 Prostaglandin reductase inhibitors ABGENOMICS CORPORATION (TW) 2009-05-14 — — US disclosed
US-20090124688-A1 Prostaglandin reductase inhibitors ABGENOMICS CORPORATION (TW) 2009-05-14 — — US disclosed
US-20080160347-A1 Benzofluorene compound, emission materials and organic electroluminescent device JNC CORPORATION (JP) 2008-07-03 — — US disclosed
US-20080105865-A1 Pyrene Based Compound and Light Emitting Transistor Element Using the Same PIONEER CORPORATION (JP) 2008-05-08 — — US disclosed
US-20080012475-A1 Pyrene Based Compound, And Light Emitting Transistor Element And Electroluminescence Element Using The Same MITSUBISHI CHEMICAL CORPORATION (JP) 2008-01-17 — — US disclosed
EP-1818322-A1 PYRENE COMPOUND AND, UTILIZING THE SAME, LIGHT EMITTING TRANSISTOR DEVICE AND ELECTROLUMINESCENCE DEVICE Rohm Co., Ltd. (JP) 2007-08-15 — — EP disclosed
EP-1816114-A1 PYRENE COMPOUND AND LIGHT EMITTING TRANSISTOR DEVICE UTILIZING THE SAME Rohm Co., Ltd. (JP) 2007-08-08 — — EP disclosed
WO-2007082178-A2 PROSTAGLANDIN REDUCTASE INHIBITORS ABGENOMICS CORPORATION (TW) 2007-07-19 — — WO disclosed
EP-0030703-B1 PROCESS FOR THE PREPARATION OF COUMARIN COMPOUNDS BASF Aktiengesellschaft (DE) 1984-03-21 — — EP disclosed
US-3985763-A DYESTUFFS BAYER AKTIENGESELLSCHAFT (DT) 1976-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360158-A1 POLYCYCLIC AROMATIC COMPOUND ETV6, EML4, ELOC PIK3CD 1443/4885PIK3CB 1699/4885KDM4E 518/4885
US-11877506-B2 Polycyclic aromatic compound F11, C1R, RNF31 PIK3CD 4237/4885PIK3CB 4328/4885KDM4E 4253/4885
US-20080160347-A1 Benzofluorene compound, emission materials and organic electroluminescent device LEF1, TRPA1, BRD8 PIK3CD 3872/4885PIK3CB 3770/4885KDM4E 1083/4885
US-20250081847-A1 POLYCYCLIC AROMATIC COMPOUND PAH, ALK, AOC2 PIK3CD 2154/4885PIK3CB 1596/4885KDM4E 1365/4885
US-20080105865-A1 Pyrene Based Compound and Light Emitting Transistor Element Using the Same CYP1A1, SULT1A1, SULT1E1 PIK3CD 4812/4885PIK3CB 4757/4885KDM4E 3667/4885
US-12473315-B2 Polycyclic aromatic compound PAH, ALK, AOC2 PIK3CD 2154/4885PIK3CB 1596/4885KDM4E 1365/4885
US-20080012475-A1 Pyrene Based Compound, And Light Emitting Transistor Element And Electroluminescence Element Using The Same ARNT, ESR1, TEAD4 PIK3CD 4671/4885PIK3CB 4597/4885KDM4E 3871/4885
US-20090124688-A1 Prostaglandin reductase inhibitors PTGIR, PTGDR, PTGDR2 PIK3CD 2914/4885PIK3CB 2480/4885KDM4E 2123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback